Rapport Therapeutics, Inc.
Biotechnology
Rapport Therapeutics is a biotechnology company focused on developing precision medicines for neurological disorders. It utilizes receptor-associated proteins to identify small molecule drugs that modulate neurotransmitter receptors, aiming for greater efficacy and reduced side effects.
Founded: 2022
Abraham Ceesay Chief Executive Officer |
Troy Ignelzi Chief Financial Officer |
Swamy Yeleswaram, Ph.D. Chief Development Officer |
Karina Chmielewski Chief Information Officer & Head of Operations |
Kathy Wilkinson Chief People Officer |
David Bredt, Ph.D. Co-Founder & Chief Scientific Officer |
Steven Paul, MD Co-Founder & Chairman |
Brad Galer, MD Chief Medical Officer |
Cheryl Gault Chief Operating Officer |